29
Fri, Mar
48 New Articles

Wolf Theiss Advises lifebrain on Purchase of Guidonia Group

Austria
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Wolf Theiss has advised lifebrain, a medical diagnostic laboratory group headquartered in Austria, on its acquisition of the Italian Guidonia Group. 

lifebrain was established in 2003 by the former majority shareholder of Futurelab Group and other private shareholders and -- according to Wolf Theiss -- is currently the fastest growing medical diagnostic laboratory group in Europe. "We started our operational business with the acquisition of Labtop AG in Switzerland six months ago and since then have managed to increase our turnover to approx. EUR 20 million through four successful acquisitions, among them the largest cytologic laboratory in Switzerland," said Michael Havel, the CEO and co-founder of lifebrain. "Guidonia is a very important first step in our strategy to become the leading player in the geographical area of Rome and Southern Italy." Bernhard Auer, CFO of lifebrain, added: "We have already identified a substantial number of further targets, both in the DACH region as well as in Italy and have equity funds readily available to invest approx. EUR 100 million within the next 6 months."

We have worked with the management team of lifebrain for more than 10 years on some 45 successful acquisitions and are proud to be able to assist also in this new dynamic and progressive venture of lifebrain," said Wolf Theiss Partner Dieter Spranz, who advises lifebrain on all corporate law matters. The Milan and Rome offices of Latham & Watkins advised on the Italian law aspects of the Guidona transaction and BDO acted as financial adviser to lifebrain.

 

 

Our Latest Issue